Difficulty: Medium
Average Score: 72%
Practice
A healthcare professional is preparing to administer Pamidronate to a client who has bone pain related to cancer. Which of the following precautions should the healthcare professional take when administering pamidronate?
Correct answer
B
Rationale
In this scenario, option B, "Assess the IV site for thrombophlebitis frequently during administration," is the correct precaution when administering Pamidronate to a client with bone pain related to cancer. Pamidronate is a bisphosphonate medication used to treat high blood calcium levels and bone problems that may occur with certain types of cancer. Bisphosphonates can irritate veins and cause inflammation, leading to thrombophlebitis. Monitoring the IV site for signs of thrombophlebitis is crucial to prevent complications and ensure the client's safety during administration.
Option A, "Inspect the skin for redness and irritation when changing the intradermal patch," is incorrect as Pamidronate is not administered via an intradermal patch, so this precaution is irrelevant to its administration.
Option C, "Instruct the client to sit upright or stand for 30 min following oral administration," is incorrect as Pamidronate is not typically administered orally. It is usually given intravenously, making this precaution unnecessary for this medication.
Option D, "Watch for manifestations of anaphylaxis for 20 min after IM administration," is incorrect because Pamidronate is not typically administered intramuscularly. Anaphylaxis is a severe allergic reaction that can occur with any medication, but this precaution is not specific to Pamidronate administration in this case.
Educationally, understanding the specific administration routes, side effects, and precautions associated with different medications is crucial for healthcare professionals to ensure safe and effective patient care. By knowing the correct precautions for each medication, healthcare professionals can minimize risks and optimize treatment outcomes for their patients.
Option A, "Inspect the skin for redness and irritation when changing the intradermal patch," is incorrect as Pamidronate is not administered via an intradermal patch, so this precaution is irrelevant to its administration.
Option C, "Instruct the client to sit upright or stand for 30 min following oral administration," is incorrect as Pamidronate is not typically administered orally. It is usually given intravenously, making this precaution unnecessary for this medication.
Option D, "Watch for manifestations of anaphylaxis for 20 min after IM administration," is incorrect because Pamidronate is not typically administered intramuscularly. Anaphylaxis is a severe allergic reaction that can occur with any medication, but this precaution is not specific to Pamidronate administration in this case.
Educationally, understanding the specific administration routes, side effects, and precautions associated with different medications is crucial for healthcare professionals to ensure safe and effective patient care. By knowing the correct precautions for each medication, healthcare professionals can minimize risks and optimize treatment outcomes for their patients.